Zum Inhalt

Comparative analysis of surgical site infection rates between transumbilical and periumbilical incisions in laparoscopic cholecystectomy: a randomized controlled trial

  • Open Access
  • 06.05.2025
Erschienen in:
download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Laparoscopic cholecystectomy is the standard treatment for gallstone disease offering advantages such as minimal incision size and rapid recovery. The study compares the surgical site infection (SSI) rates between transumbilical (TUI) and periumbilical incisions (PUI) in this method.

Methods

A randomized controlled trial was conducted from December 2021 to December 2023 at Panyananthaphikkhu Chonprathan Medical Center, Thailand. Patients undergoing laparoscopic cholecystectomy were randomly assigned to TUI or PUI groups. The primary endpoint was SSI rate, with secondary endpoints including length of hospital stay, operative time, blood loss, conversion rate, complications, cosmetic satisfaction, pain score, wound hypersensitivity, and numbness.

Results

A total of 156 patients were enrolled, with 78 patients in each group. The incidence of SSI was 14.1% in the TUI group and 10.3% in the PUI group (p = 0.46). There were no conversions to open surgery, bile leaks, intra-abdominal infections, reoperations, or mortalities observed in either group. Outcomes related to cosmetic satisfaction, wound numbness, and wound hypersensitivity were comparable between the groups. Patients who developed SSI demonstrated lower cosmetic satisfaction scores on postoperative day 7 surgery (8.47 ± 1.3) compared to those without SSI (9.5 ± 0.8) (p < 0.001), although these scores were similar by day 30. Additionally, the SSI group exhibited a higher prevalence of umbilical wound hypersensitivity on day 30 post-surgery [11 (57.9%) vs. 35 (25.7%), p = 0.04].

Conclusions

SSI rates and other surgical outcomes were comparable between TUI and PUI in laparoscopic cholecystectomy, encouraging the use of either technique based on surgeon preference and patient-specific factors.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Laparoscopic surgery was first pioneered in 1901 by Georg Kelling [1], since then this technique has gained widespread popularity across various surgical fields, including basic procedures like hernia repair, appendectomy, and cholecystectomy, as well as more complex operations such as hepatectomy and pancreaticoduodenectomy [2, 3].
Laparoscopic cholecystectomy was initiated in 1985, and it has since become the standard treatment for symptomatic cholelithiasis. Its popularity is due to its advantages: minimal incision size, reduced postoperative pain, quicker mobility, rapid recovery, favorable cosmetic results, and faster return to work [4, 5]. The incision at the umbilicus for the camera port is fundamental in creating pneumoperitoneum. Surgeon preference determines whether the first incision for the camera port is a vertical transumbilical incision (TUI), avoiding sheath penetration, or a U-shaped incision above or below the umbilicus, traversing each layer of the abdomen to access the peritoneum. Both periumbilical incision (PUI) and TUI have gained popularity worldwide [6, 7].
The convergence of the skin, fascia, and peritoneum at the apex of the umbilicus creates a shallow area, making abdominal cavity access easier, and particularly beneficial for obese patients. Additionally, this dissection plan is relatively bloodless [8, 9]. The advantage of the TUI lies in its scar hidden within the umbilicus, but concerns exist regarding umbilical herniation and surgical site infections (SSI) due to the moisture environment and challenges in wound dressing [7, 1012]. Consequently, some surgeons may opt not to use this incision in their practice.
Previous randomized controlled trials (RCTs) yielded varying results on SSI outcomes related to the incision choice [13, 14]. This study’s objective is to examine the SSI rate in patients with TUI and PUI. Secondary endpoints are the length of hospital stays, operative time, blood loss, conversion rate, post-laparoscopic cholecystectomy complications such as bile leakage and intraabdominal infection, cosmetic satisfaction, pain score, wound hypersensitivity, and numbness.

Materials and methods

The RCT was conducted from December 2021 to December 2023 at Panyananthaphikkhu Chonprathan Medical Center (PCMC), Nonthaburi, Thailand, a single tertiary medical center. The trial was registered with the Thai Clinical Trials Registry (TCTR) (ID TCTR20231012002) and approved by the Institutional Review Board of PCMC with the ID EC 014/64. The study adheres to the CONSORT guideline [15]. Inclusion criteria were patients over 18 undergoing laparoscopic cholecystectomy, while exclusion criteria included patients with acute cholecystitis, pregnancy, immunocompromised status, ascites, and those receiving peritoneal dialysis.
Patients were randomly assigned to two groups, PUI and TUI at a 1:1 allocation ratio. All patients provided written consent to enroll in the study. Sealed opaque envelopes with notes marked with either transumbilical or periumbilical, were placed in the operating room. A perioperative antibiotic regimen consisting of a third-generation cephalosporin was administered intravenously within 30 min prior to incision. The antibiotic therapy was continued for less than 24 h postoperatively. In patients with cephalosporin allergies, a quinolone antibiotic was administered as an alternative. Following general anesthesia, surgeons selected an envelope and followed the incision instructions.
The surgical procedure involved creating a camera port incision, either a vertical transumbilical or a periumbilical incision. The periumbilical incision could be either horizontal supraumbilical or infraumbilical. The open Hasson technique was employed for abdominal entry. A 12-mm trocar port was inserted after the abdominal wall was opened, pneumoperitoneum was established, and a 10-mm camera was introduced for intraperitoneal inspection. Subsequently, two or three working 5 mm ports were added. The gallbladder was retracted, Calot’s triangle dissected, and the cystic duct and artery clipped and divided. The gallbladder was dissected from the liver bed, with any bile spillage or contamination promptly controlled. The specimen was placed in a bag to prevent contamination during removal through the umbilical incision. Closure of the fascia was performed using J-shaped needle interrupted absorbable polyglactin Novosyn® 2–0 sutures, while the skin was closed with subcuticular glyconate monofilament Monosyn® 4–0 sutures. Sterile strips were then applied for wound closure.
Patient demographics, perioperative details, and postoperative data of the patients were extracted from recorded documents. Follow-up assessments were conducted up to 30 days post-surgery, with SSI as the primary focus. SSI was defined according to the Centers for Disease Control (CDC) guidelines, defining infections occurring within 30 days post-procedure, exhibiting symptoms like purulent drainage, pain, tenderness, swelling, redness, wound dehiscence, or positive cultures [16]. SSI assessments were carried out before discharge, as well as at 7- and 30-day post-surgery. Secondary outcomes included length of hospital stays, operative time, blood loss, conversion rate, post-laparoscopic cholecystectomy complications, cosmetic satisfaction, pain score, wound hypersensitivity, and numbness. Pain levels were assessed 24- and 48-h post-operation using a visual analogue scale (VAS) ranging from 0 to 10. Cosmetic satisfaction was appraised using a VAS at both 7 and 30 days after the surgery, also on a scale of 0 to 10.
The sample size was determined based on a study by Siribumrungwong et al., indicating a 4% SSI rate for PUI compared to 16% for TUI three months postoperatively [14]. The sample size calculation assumed a two-sided alpha level of 5% and a power of 80%, resulting in a target of 71 participants per group. Accounting for a 10% potential loss to follow-up, resulted in a total of 78 participants.
The statistical analysis was conducted using IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA). Continuous variables were presented as mean ± standard deviation. Categorical variables were compared using the chi-square test or Fisher’s exact test, while differences in continuous variables between groups were assessed using the Student’s t-test. P-value < 0.05 was considered statistically significant.

Results

A total of 156 patients were enrolled, with 78 patients assigned to both the PUI and TUI groups as shown in Fig. 1. Demographic data, as depicted in Table 1, were comparable between the two groups, with none presenting liver disease. More than half of the patients in both groups presented as symptomatic gallstones along with a similar proportion presenting comorbidities. Morbid obesity was observed in 6 patients (7.7%) in each group. Pathological reports indicated chronic cholecystitis in all cases, except for one patient in the TUI group, who had a gallbladder polyp.
Fig. 1
CONSORT flow diagram
Bild vergrößern
Table 1
Baseline characteristics of the patients
Variables
Transumbilical (n = 78)
Periumbilical (n = 78)
P-value
Age, years, mean ± SD
53.91 (14.61)
56.19 (16.11)
0.67
Gender (male/female), n (%)
28 (35.9)
33 (42.3)
0.41
BMI, kg/m2, mean ± SD
26.24 (5.01)
25.74 (5.83)
0.51
ASA classification, n (%)
  
0.46
 I
6 (7.7)
8 (10.3)
 
 II
43 (55.1)
43 (55.1)
 
 III
29 (37.2)
25(32.1)
 
 IV
0
2 (1.3)
 
Comorbidities, n (%)
45 (57.7)
43 (55.1)
0.75
Hypertension, n (%)
34 (43.6)
36 (46.2)
0.75
Diabetes mellitus, n (%)
19 (24.4)
25 (32.1)
0.29
Cardiac disease, n (%)
4 (5.1)
8 (10.3)
0.23
Cerebrovascular disease, n (%)
3 (3.8)
4 (5.1)
0.7
Chronic kidney disease, n (%)
5 (6.4)
2 (2.6)
0.25
Morbid obesity, n (%)
6 (7.7)
6 (7.7)
1
Preoperative diagnosis
  
0.24
 History cholecystitis, n (%)
17 (21.8)
21 (26.9)
 
 Symptomatic gallstone, n (%)
44 (56.4)
43 (55.1)
 
 Gallbladder polyp, n (%)
4 (5.1)
0
 
 History common bile duct stone, n (%)
9 (11.5)
12 (15.4)
 
 Gallstone pancreatitis (%)
4 (5.1)
2 (2.6)
 
ASA American Society of Anesthesiologists, BMI body mass index, PUI periumbilical incision, TUI transumbilical incision
The outcomes in Table 2 reveal comparable SSI rates between the TUI and PUI groups, 11 (14.1%) and 8 (10.3%) respectively (p = 0.46). If the specimen was larger than the incision, an extension of the sheath and skin was performed; however, the total length of the incision did not exceed 2 cm (cm). Neither group experienced conversions to open surgery, bile leaks, intraabdominal infections, reoperations, nor mortality. However, one patient in the TUI group required a blood transfusion due to a blood loss of 800 ml. In the PUI group, two patients experienced atrial fibrillation with rapid ventricular response, which resolved quickly, leading to discharge on postoperative days 3 and 6 without SSI. Also, one patient in the TUI group experienced atrial fibrillation with rapid ventricular response, lung atelectasis, and SSI, resulting in discharge on postoperative day 11. Cosmetic satisfaction, wound numbness, and wound hypersensitivity outcomes were similar in both groups, with no occurrences of umbilical hernia 30 days post-surgery.
Table 2
Outcomes of the patients
Variables
TUI (n = 78)
PUI (n = 78)
P-value
Surgical site infection, n (%)
11 (14.1)
8 (10.3)
0.46
Operative time, minutes, mean ± SD
84.27 (36.76)
79.68 (28.84)
0.85
Blood loss, mL, median (min,max)
10 (2,800)
10 (0,350)
0.72
Post-operative length of stay, day, mean ± SD
1.85 (1.32)
1.69 (0.92)
0.46
Intraoperative blood transfusion, n (%)
1 (1.3)
0
0.32
Drain insertion, n (%)
7 (9)
7 (9)
1
Complications, overall, n (%)
1 (1.3)
2 (2.6)
0.56
Clavien-Dindo classification, n (%)
  
0.56
 I
0
0
 
 II
1 (1.3)
2 (2.6)
 
 III
0
0
 
 IV
0
0
 
 IV
0
0
 
Postoperative pain VAS score at 24 h, mean ± SD
4.69 (2.1)
4.48 (2.3)
0.22
Postoperative pain score at 48 h, mean ± SD
3.86 (1.7)
3.03 (2.2)
0.29
Cosmetic satisfaction VAS score at day 7, mean ± SD
9.33 (0.98)
9.42 (0.91)
0.92
Cosmetic satisfaction VAS score at day 30, mean ± SD
9.43 (0.83)
9.53 (0.66)
0.11
Umbilical wound numbness at day 7, n (%)
6 (7.7)
6 (7.7)
1
Umbilical wound numbness at day 30, n (%)
4 (5.1)
4 (5.1)
0.99
Umbilical wound hypersensitivity at day 7, n (%)
31 (39.7)
22 (28.2)
0.13
Umbilical wound hypersensitivity at day 30, n (%)
22 (28.6)
24 (30.8)
0.77
PUI periumbilical incision, TUI transumbilical incision, VAS visual analogue scale
Factors contributing to SSI were analyzed, with none found to be significant, as shown in Table 3. None of the morbidly obese and chronic kidney disease patients have SSI. Patients with SSI exhibited lower cosmetic satisfaction scores on day 7 post-surgery (8.47 ± 1.3) compared to the non-SSI group (9.5 ± 0.8) (p < 0.001). However, cosmetic VAS scores were comparable between both groups on day 30 (9.16 ± 1 vs 9.52 ± 0.7, p = 0.19). The SSI group demonstrated a higher prevalence of umbilical wound hypersensitivity at day 30 post-surgery [11 (57.9%) vs 35(25.7%), p = 0.04]. Postoperative pain scores and wound numbness did not differ between the groups, as demonstrated in Table 4.
Table 3
Factors the patients with and without surgical site infection
Variables
SSI (n = 19)
NO SSI (n = 137)
P-value
Age, years, mean ± SD
55.05 (16.9)
55.05 (15.2)
0.79
Gender (male/female), n (%)
4 (21.1)
57 (41.61)
0.09
BMI, kg/m2, mean ± SD
26.24 (4.29)
25.95 (5.57)
0.62
ASA classification, n (%)
  
0.8
 I
2 (10.5)
12 (8.8)
 
 II
12 (63.2)
74 (54)
 
 III
5 (26.3)
49 (35.8)
 
 IV
0
2 (1.5)
 
Comorbidities, n (%)
10 (52.6)
78 (56.9)
0.72
Hypertension, n (%)
9 (47.4)
61 (44.5)
0.82
Diabetes mellitus, n (%)
6 (31.6)
38 (27.7)
0.73
Cardiac disease, n (%)
2 (10.5)
10 (7.3)
0.62
Cerebrovascular disease, n (%)
0
7 (5.1)
0.31
Chronic kidney disease, n (%)
0
7 (5.1)
0.31
Morbid obesity, n (%)
0
12 (8.8)
0.18
Preoperative diagnosis
  
0.89
 History cholecystitis, n (%)
4 (21.1)
34 (24.8)
 
 Symptomatic gallstone, n (%)
12 (63.2)
75 (54.7)
 
 Gallbladder polyp, n (%)
0
4 (2.9)
 
 History common bile duct stone, n (%)
2 (10.5)
19 (13.9)
 
 Gallstone pancreatitis (%)
1 (5.3)
5 (3.6)
 
 Operative time, minutes, mean ± SD
85.79 (44.9)
81.45 (31.2)
0.37
 Blood loss, mL, median (min,max)
10 (2,100)
10 (0,800)
0.97
 Post-operative length of stay, day, mean ± SD
2.16 (2.3)
1.72 (0.9)
0.13
 Intraoperative blood transfusion, n (%)
0
1 (0.7)
0.71
 Drain insertion, n (%)
3 (15.8)
11 (8)
0.27
ASA American Society of Anesthesiologists, BMI body mass index, SSI surgical site infection
Table 4
Outcome of the patients with and without surgical site infection
Variables
SSI (n = 19)
NO SSI (n = 137)
P-value
Postoperative pain VAS score at 24 h, mean ± SD
4 (1.7)
4.67 (2.2)
0.42
Postoperative pain score at 48 h, mean ± SD
2.52 (1.4)
3.58 (2)
0.33
Cosmetic satisfaction VAS score at day 7, mean ± SD
8.47 (1.3)
9.5 (0.8)
 < 0.001
Cosmetic satisfaction VAS score at day 30, mean ± SD
9.16 (1)
9.52 (0.7)
0.19
Umbilical wound numbness at day 7, n (%)
1 (5.3)
11 (8)
0.67
Umbilical wound numbness at day 30, n (%)
1 (5.3)
7 (5.1)
0.98
Umbilical wound hypersensitivity at day 7, n (%)
7 (36.8)
46 (33.6)
0.78
Umbilical wound hypersensitivity at day 30, n (%)
11 (57.9)
35 (25.7)
0.004
SSI surgical site infection, VAS visual analogue scale

Discussion

Both PUI and TUI are popular surgical approaches worldwide [6, 7]. The advantages of the TUI were less time-consuming to reach intraperitoneal and more useful in morbidly obese patients due to their thick subcutaneous fat [7]. However, this study did not record the time for opening or wound closure, making it difficult to confirm the time-saving benefit of the TUI approach. Previous RCTs on SSI in laparoscopic cholecystectomy have yielded conflicting results. One study reported no significant difference, with a 16% SSI rate for TUI compared to 4% for PUI [14]. Another study found a significant difference, with 0% SSIs in TUI compared to 3% in PUI [13]. However, a meta-analysis concluded that there were no significant differences in SSI rates between the two methods [17]. Our RCT findings align with this meta-analysis, showing no significant difference in SSI rates between TUI and PUI (14.1% for TUI vs. 10.3% for PUI, p = 0.46). The concern of the surgical site of TUI did not increase the infection rate [10, 11]. Therefore, if the surgeon prefers the TUI, it suggests that surgeons can choose either incision based on their preference without increasing the risk of infection [8, 9].
In terms of intraoperative outcomes, our study found no significant differences in operative time, blood loss, or blood transfusion requirements between the two incision types. Additionally, there were no conversions to open surgery, bile leaks, intra-abdominal infections, reoperations, or mortalities in either group, indicating that both methods are safe for patients.
Consistent with the previous study, we found similar results for cosmetic satisfaction, wound numbness, and wound hypersensitivity, with no occurrences of umbilical hernia 30 days post-surgery [13]. Therefore, we conclude that there are no significant differences between PUI and TUI in terms of operative procedures, wound outcomes, and overall short-term safety.
Regarding cosmetic satisfaction, the appearance of the umbilicus is important to some patients, with 28–39% considering it a significant aspect of their overall appearance [18, 19]. It was previously mentioned that the TUI incision, by hiding the scar, would result in higher patient satisfaction [13]. However, our study found no significant difference in cosmetic satisfaction between the two groups at one week and one month post-surgery, which supports earlier research [8, 18]. Similarly, wound numbness and hypersensitivity were comparable between the two groups. Thus, cosmetic concerns should not determine the choice of incision type.
Umbilical hernias at the trocar site are classified into three distinct types. The first type is early-onset, which typically manifests immediately postoperatively, often due to surgical technique. The second type, late-onset hernia, occurs several months after the surgical procedure. The third type is characterized by the protrusion of intra-abdominal contents, such as the intestine and/or omentum [20]. In studies with shorter follow-up durations, the incidence of umbilical hernias was reported to be low, ranging from 0.18 to 2.8% [21]. However, with extended follow-up periods, the incidence increases, with the time to occurrence ranging from 9 to 70 months, with a median of 42.4 months [22]. To more accurately assess the true risk of incisional hernias, a follow-up period of at least 3 years is recommended [22, 23]. Longer follow-up periods have shown an increased incidence of 11.7–12.1% [21, 22]. Several factors have been identified as contributing to the increased incidence of umbilical hernias, including high body mass index (BMI), a prior history of umbilical hernia, incision length greater than 5 cm, and prolonged operative time [22]. In patients undergoing laparoscopic sleeve gastrectomy, the incidence of umbilical hernias was as high as 21.5%, with a mean follow-up period of 37 months [23]. This particular study, with only a 30-day follow-up and no occurrences, showed results consistent with those of a previous study [7]. Thus, short follow-up periods may only detect early-onset hernias. Further studies with extended follow-up are warranted to evaluate the long-term outcomes and potential risk factors associated with umbilical hernias.
Factors influencing SSI include patient factors such as age, nutritional status, and obesity; procedural factors, with laparoscopic approaches generally tending to lower SSI incidence; and microbial factors [16, 24, 25]. Studies have shown that umbilical flora and bile are not the primary sources of SSIs in laparoscopic surgeries. Instead, hospital-acquired pathogens or intra-abdominal contamination are more likely responsible for infections [10, 26]. Interestingly, in our study, patient status was not found to significantly affect SSI rates, and none of the patients with renal disease and morbid obesity encountered SSI. However, the low number of patients with SSIs suggests that the sample size may have been insufficient to evaluate significant differences, which could explain the discrepancy with previous studies. Patients who developed SSIs also reported higher wound hypersensitivity and lower cosmetic satisfaction, which is consistent with expectations.
Our study does have limitations, including being a single-center study with a short follow-up period. Future research should focus on larger, multicenter trials and long-term outcomes, including incision opening and closing times, umbilical hernia occurrence, wound numbness, hypersensitivity, and cosmetic results to provide a more precise agreement.

Conclusions

This study shows that there is no statistically significant difference in SSI rates between TUI and PUI in laparoscopic cholecystectomy, indicating that both incision types are practicable options with comparable outcomes regarding operative safety and overall patient satisfaction. This finding supports the use of either practice based on surgeon preference and patient-specific considerations.

Acknowledgements

None.

Declarations

Disclosures

Vorapatu Tangsirapat, Mati Rattanasakalwong, Jantaluck Nuchanatanon, Vittawat Ohmpornnuwat, Papot Charutragulchai, Singha Sripreechapattana, Panutchaya Kongon, and Kitti Wongta, have no conflicts of interest or financial ties to disclose.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie + umfangreiches Online-Angebot

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Chirurgie

Kombi-Abonnement

Mit e.Med Chirurgie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Chirurgie, den Premium-Inhalten der chirurgischen Fachzeitschriften, inklusive einer gedruckten chirurgischen Zeitschrift Ihrer Wahl.

download
DOWNLOAD
print
DRUCKEN
Titel
Comparative analysis of surgical site infection rates between transumbilical and periumbilical incisions in laparoscopic cholecystectomy: a randomized controlled trial
Verfasst von
Vorapatu Tangsirapat
Mati Rattanasakalwong
Jantaluck Nuchanatanon
Vittawat Ohmpornnuwat
Papot Charutragulchai
Singha Sripreechapattana
Panutchaya Kongon
Kitti Wongta
Publikationsdatum
06.05.2025
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 6/2025
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-025-11770-w
1.
Zurück zum Zitat Abdelmaksoud A, Biyani CS, Bagheri F, Janetschek G (2005) Laparoscopic approaches in urology. BJU Int 95:244–249CrossRefPubMed
2.
Zurück zum Zitat Tiwari MM, Reynoso JF, High R, Tsang AW, Oleynikov D (2011) Safety, efficacy, and cost-effectiveness of common laparoscopic procedures. Surg Endosc 25:1127–1135CrossRefPubMed
3.
Zurück zum Zitat Wongta K, Rattanasakalwong M, Nuchanatanon J, Charutragulchai P, Tangsirapat V (2024) Laparoscopic versus open liver resection for treatment of liver tumors: early experience outcomes. Formos J Surg 57:11–16CrossRef
4.
Zurück zum Zitat Macintyre IM, Wilson RG (1993) Laparoscopic cholecystectomy. Br J Surg 80:552–559CrossRefPubMed
5.
Zurück zum Zitat Sanford DE (2019) An update on technical aspects of cholecystectomy. Surg Clin North Am 99:245–258CrossRefPubMed
6.
Zurück zum Zitat Compeau C, McLeod NT, Ternamian A (2011) Laparoscopic entry: a review of Canadian general surgical practice. Can J Surg 54:315–320CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Lee JS, Hong TH, Kim JG (2012) A comparison of the periumbilical incision and the intraumbilical incision in laparoscopic appendectomy. J Korean Surg Soc 83:360–366CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Şentürk MB, Doğan O, Polat M, Kılıçcı Ç, Pulatoğlu Ç, Tayyar AT (2018) Cosmetic outcomes of infraumbilical, supraumbilical, and transumbilical entry routes in laparoscopic surgery. Turk J Surg 34:290–294PubMedPubMedCentral
9.
Zurück zum Zitat Kadar N (1997) A new technique of primary trocar insertion for laparoscopy. J Am Assoc Gynecol Laparosc 4:485–489CrossRefPubMed
10.
Zurück zum Zitat Kleeff J, Erkan M, Jäger C, Menacher M, Gebhardt F, Hartel M (2015) Umbilical microflora, antiseptic skin preparation, and surgical site infection in abdominal surgery. Surg Infect (Larchmt) 16:450–454CrossRefPubMed
11.
Zurück zum Zitat Watson EGR, Cobden EJ, Vasey CE (2021) A pilot randomised controlled trial of patient education to improve umbilical cleanliness prior to laparoscopic surgery. ANZ J Surg 91:2650–2655CrossRefPubMed
12.
Zurück zum Zitat Sharples A, McArthur D, McNamara K, Lengyel J (2011) Back to basics–cutting the cord on umbilical infections. Ann R Coll Surg Engl 93:120–122CrossRefPubMed
13.
Zurück zum Zitat Lee JS, Hong TH (2016) Intraumbilical versus periumbilical incision in laparoscopic cholecystectomy: a randomized controlled trial. Int J Surg 33:83–87CrossRefPubMed
14.
Zurück zum Zitat Siribumrungwong B, Chunsirisub T, Limpavitayaporn P, Tongyoo A, Sriussadaporn E, Mingmalairak C, Thowprasert W, Thakkinstian A (2019) Comparison of postoperative pain at umbilical wound after conventional laparoscopic cholecystectomy between transumbilical and infraumbilical incisions: a randomized control trial. Surg Endosc 33:1578–1584CrossRefPubMed
15.
Zurück zum Zitat Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 8:18CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250–280CrossRefPubMed
17.
Zurück zum Zitat Shih SL, Chen BH, Tam KW (2020) Transumbilical versus periumbilical incision for laparoscopic surgery: a meta-analysis. Am J Surg 220:1592–1598CrossRefPubMed
18.
Zurück zum Zitat Bouffard-Cloutier A, Paré A, McFadden N (2017) Periumbilical vs transumbilical laparoscopic incision: a patients’ satisfaction-centered randomised trial. Int J Surg 43:86–91CrossRefPubMed
19.
Zurück zum Zitat Iranmanesh P, Morel P, Inan I, Hagen M (2011) Choosing the cosmetically superior laparoscopic access to the abdomen: the importance of the umbilicus. Surg Endosc 25:2578–2585CrossRefPubMed
20.
Zurück zum Zitat Tonouchi H, Ohmori Y, Kobayashi M, Kusunoki M (2004) Trocar site hernia. Arch Surg 139:1248–1256CrossRefPubMed
21.
Zurück zum Zitat Li M, Cao B, Gong R, Sun D, Zhang P, Jiang X, Sheng Y (2018) Randomized trial of umbilical incisional hernia in high-risk patients: extraction of gallbladder through subxiphoid port vs. umbilical port after laparoscopic cholecystectomy. Wideochir Inne Tech Maloinwazyjne 13:342–349PubMedPubMedCentral
22.
Zurück zum Zitat Watanabe J, Ishibe A, Suwa Y, Suwa H, Ota M, Kubota K, Yamanaka T, Kunisaki C, Endo I (2021) Hernia incidence following a randomized clinical trial of single-incision versus multi-port laparoscopic colectomy. Surg Endosc 35:2465–2472CrossRefPubMed
23.
Zurück zum Zitat Ahlqvist S, Edling A, Alm M, Dackhammar JB, Nordin P, Cengiz Y (2022) Trocar site hernia after gastric sleeve. Surg Endosc 36:4386–4391CrossRefPubMed
24.
Zurück zum Zitat Richards C, Edwards J, Culver D, Emori TG, Tolson J, Gaynes R (2003) Does using a laparoscopic approach to cholecystectomy decrease the risk of surgical site infection? Ann Surg 237:358–362CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Fahrner R, Malinka T, Klasen J, Candinas D, Beldi G (2014) Additional surgical procedure is a risk factor for surgical site infections after laparoscopic cholecystectomy. Langenbecks Arch Surg 399:595–599CrossRefPubMed
26.
Zurück zum Zitat Hamzaoglu I, Baca B, Böler DE, Polat E, Ozer Y (2004) Is umbilical flora responsible for wound infection after laparoscopic surgery? Surg Laparosc Endosc Percutan Tech 14:263–267CrossRefPubMed

Neu im Fachgebiet Chirurgie

Obstruktive Parotitis: Bringt eine Gangdilatation die gewünschte Erleichterung?

Ist eine Speichelgangsblockade und die damit verbundene Sialadenitis nicht durch Steine bedingt, wird oftmals versucht, die Symptomatik zu lindern, indem man den Gang mechanisch weitet. Ein aktuelles Review kann den Eingriff als chancenreiches Verfahren bestätigen und deckt gleichzeitig Schwächen auf.

Video

S2e-Leitlinie Hallux valgus

Mehr als eine Million Menschen in Deutschland leiden unter Hallux valgus – eine Fehlstellung des Großzehs, die je nach Schweregrad und Symptomen behandelt wird. Welche neuen Empfehlungen die aktualisierte S2e-Leitlinie bietet, erklärt der Orthopäde Prof. Sebastian Baumbach im MedTalk Leitlinie KOMPAKT der Zeitschrift Orthopädie und Unfallchirurgie.

MedTalk Leitlinie KOMPAKT

Krankenkassen erklären sich bereit, therapeutische Wundprodukte weiterhin zu erstatten

  • 05.12.2025
  • EBM
  • Nachrichten

Aktuell gesteigertes Regressrisiko bei der Verordnung therapeutischer Wundauflagen? Vielerorts signalisieren Kassen und KVen schon Entwarnung.

Hyperparathyreoidismus: Operation kann vor Diabetes schützen

Ein chirurgischer Eingriff kann für Patienten mit primärem Hyperparathyreoidismus gegenüber dem konservativen Management metabolisch von Vorteil sein. Denn wie eine Studie zeigt, senkt die Operation das Diabetesrisiko.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Operation an der Hand/© karegg / stock.adobe.com (Symbolbild mit Fotomodellen), Versorgung einer infizierten Wunde bei diabetischem Fuß/© kirov1969 / Stock.adobe.com (Symbolbild mit Fotomodellen), Narbe an Hals einer Frau nach Operation/© SusaZoom / stock.adobe.com (Symbolbild mit Fotomodell)